CÉLULAS MADRE Y TERAPIA CELULAR
John Radcliffe Hospital
Oxford, Reino UnidoPublicaciones en colaboración con investigadores/as de John Radcliffe Hospital (1)
2018
-
Missense Mutations of the Pro65 Residue of PCGF2 Cause a Recognizable Syndrome Associated with Craniofacial, Neurological, Cardiovascular, and Skeletal Features
American Journal of Human Genetics, Vol. 103, Núm. 5, pp. 786-793